EQL Pharma Investor Relations

General Meetings

According to the Swedish Companies Act, the general meeting is the company’s highest decision-making body. At the annual general meeting, shareholders exercise their voting rights on key issues, such as the adoption of income statements and balance sheets, the allocation of the company’s profit, discharge from liability for the members of the board of directors and the CEO, election of board members and auditors, and remuneration to the board of directors and the auditors.

The annual general meeting must be held within six months of the end of the financial year. In addition to the annual general meeting, an extraordinary general meeting may be convened. According to the articles of association, notice of the annual general meeting is given through an announcement in the Swedish Official Gazette (Sw. Post- och Inrikes Tidningar) and by making the notice available on the company’s website. An advert regarding the notice shall at the same time be announced in Svenska Dagbladet.

Right to participate in general meetings

Shareholders who wish to participate in a general meeting must be registered in the share register maintained by Euroclear Sweden as of the day that falls six banking days prior to the meeting, and must notify the company of their intention to participate in the general meeting no later than the date stated in the notice of the meeting. Shareholders may attend general meetings in person or by proxy and may also be assisted by a maximum of two persons. Shareholders can usually give notice of attendance at the general meeting in several different ways, which are specified in more detail in the notice of the general meeting. In addition to notifying the company of their intention to participate in the general meeting, shareholders whose shares are nominee-registered through a bank or other nominee must request that their shares are temporarily registered in their own name in the share register maintained by Euroclear Sweden in order to be entitled to participate in the general meeting. A shareholder or its proxy is entitled to vote for all shares held or represented by the shareholder. The general meeting shall be held at the place where the board of directors has its registered office. However, the articles of association may stipulate that the general meeting shall or may be held at another specified location in Sweden or digitally. EQL Pharma has not adopted such a reservation in its articles of association in accordance with the provisions of the Code.

Shareholder initiatives

Shareholders who wish to have a matter considered at the general meeting must send a written request to the board of directors. The request shall normally be received by the board of directors well in advance of the general meeting, in accordance with the information provided on the company’s website in connection with the announcement of the time and place of the general meeting.